Literature DB >> 18214732

Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy.

Kouichi Tamura1, Junji Yamauchi, Yuko Tsurumi-Ikeya, Masashi Sakai, Motoko Ozawa, Atsuichiro Shigenaga, Koichi Azuma, Yasuko Okano, Tomoaki Ishigami, Yoshiyuki Toya, Machiko Yabana, Yasuo Tokita, Toshimasa Ohnishi, Satoshi Umemura.   

Abstract

The purpose of this study was to examine a possible difference in the 24-h blood pressure (BP) profile between hypertensives with diabetic nephropathy (DN) and those with non-diabetic glomerulopathy (non-DN). We measured 24-h ambulatory BP in 34 type 2 DN and 34 non-DN patients who were hospitalized for the educational program in our hospital. There were no significant differences in 24-h and daytime systolic BP between DN (143 vs. 136 mmHg, NS for 24-h systolic BP) and non-DN (143 vs. 138 mmHg, NS for daytime systolic BP). Although both groups disclosed blunted nocturnal decrease in BP and were classified as "non-dipper" type, DN patients had a significantly higher nighttime systolic BP than patients with non-DN (142 vs. 132 mmHg, p = 0.0217). BP and heart rate (HR) variabilities were also estimated, and patients with DN showed a reduced nighttime HR variability than those with non-DN (4.8 vs. 6.6 beats/min, p = 0.0115). DN patients had an increase in urinary protein excretion (3.0 vs. 1.4 g/day, p = 0.0095) and a decrease in serum albumin concentration (3.1 vs. 3.7 mg/dl, p < 0.0001). Furthermore, urinary protein excretion was significantly correlated with nighttime systolic BP (r = 0.480, p = 0.0031) but not with nighttime HR variability. Taken together, these results demonstrate that the circadian rhythms of BP and HR are affected by underlying diseases and suggest that an elevated nighttime BP level may contribute to the enhanced urinary protein excretion in hypertensives with DN.

Entities:  

Mesh:

Year:  2008        PMID: 18214732     DOI: 10.1080/10641960701813890

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

1.  Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes.

Authors:  Kouichi Tamura; Hiromichi Wakui; Kengo Azushima; Kazushi Uneda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

2.  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Authors:  Mai Yanagi; Kouichi Tamura; Tetsuya Fujikawa; Hiromichi Wakui; Tomohiko Kanaoka; Masato Ohsawa; Kengo Azushima; Akinobu Maeda; Hiroyuki Kobori; Satoshi Umemura
Journal:  Hypertens Res       Date:  2012-11-15       Impact factor: 3.872

3.  Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease.

Authors:  Cheng Wang; Jun Zhang; Wenjie Deng; Wenyu Gong; Xun Liu; Zengchun Ye; Hui Peng; Tanqi Lou
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

4.  Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.

Authors:  Ruo-Wei Wen; Xiao-Qiu Chen; Ye Zhu; Jian-Ting Ke; Yi Du; Cheng Wang; Tan-Qi Lou
Journal:  BMC Nephrol       Date:  2020-12-11       Impact factor: 2.388

Review 5.  Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

6.  Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.

Authors:  Tomohiko Kanaoka; Kouichi Tamura; Masato Ohsawa; Hiromichi Wakui; Akinobu Maeda; Toru Dejima; Kengo Azushima; Sona Haku; Hiroshi Mitsuhashi; Mai Yanagi; Jin Oshikawa; Kazushi Uneda; Kazutaka Aoki; Tetsuya Fujikawa; Yoshiyuki Toya; Kazuaki Uchino; Satoshi Umemura
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-03       Impact factor: 3.738

7.  Possible interesting link between dipping status and morning surge for subclinical target organ damage in hypertension.

Authors:  Kouichi Tamura; Kayo Waki; Yuki Kawai; Eiko Ueda; Takeo Ishii; Hiromichi Wakui
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-03       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.